Tidmarsh to Stand in for Prasad's Role at CBER

Tidmarsh to stand in for Prasad's role at CBER

Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

FDA Ousts Senior Official, Vinay Prasad – Archyde

Archyde FDA Shake-Up: Vinay Prasad’s Exit From biologics Division Sparks Industry Debate Table of Contents 1. FDA Shake-Up: Vinay Prasad’s Exit From biologics Division Sparks Industry Debate 2. To what extent… You can read the full story here: FDA Ousts Senior Official, Vinay Prasad.

Dr. Peter Marks Departs FDA Role as Head of CBER Amid Speculation on Cell and Gene Therapy Approval Changes

The recent departure of Dr. Peter Marks, the head of th […] The post Dr. Peter Marks Departs FDA Role as Head of CBER Amid Speculation on Cell and Gene Therapy Approval Changes first appeared on GeneOnline News. The post Dr. Peter Marks Departs FDA Role as Head of CBER Amid Speculation on Cell and Gene Therapy Approval Changes appeared first on GeneOnline News.

Prasad’s FDA exit may accelerate cell and gene therapy approvals - Pharmaceutical Technology

Analysts say the departure of the CBER head may alleviate overhang in the cell and gene therapy space.